Literature DB >> 1715503

Pilot study of screening for prostate cancer in general practice.

D J Chadwick1, T Kemple, J P Astley, A G MacIver, D A Gillatt, P Abrams, J C Gingell.   

Abstract

The success of a screening programme for cancer depends on the sensitivity of the tests used and on the proportion of the target population that comes forward for screening. To assess the value of digital rectal screening and prostate-specific antigen (PSA) measurement as screening measures, the 814 men in a city general practice aged between 55 and 70 were recruited in one of five different ways. Men with a palpably suspicious prostate or a serum PSA greater than 4 ng/ml were referred for transrectal ultrasonography and, if indicated, biopsy. 472 men (58%) were screened; of these 68 underwent transrectal ultrasonography and 29 biopsy. In 7 the biopsy specimen showed carcinoma. Serum PSA was better than digital examination as a screening test--all men with prostate cancer had raised concentrations of serum PSA, whereas only 1 had a palpably abnormal prostate. All 7 had localised disease, and 5 underwent radical prostatectomy. The best methods of patient recruitment were to send an appointment for screening and to "tag" the patient's notes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1715503     DOI: 10.1016/0140-6736(91)90615-v

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  10 in total

Review 1.  Adjusting for treatment refusal in rationing decisions.

Authors:  Richard Lilford; Alan Girling; Andrew Stevens; Abdullah Almasri; Mohammed A Mohammed; David Braunholtz
Journal:  BMJ       Date:  2006-03-04

Review 2.  Radical prostatectomy and prostate cancer screening: the need for national audit and research.

Authors:  R R Hall
Journal:  Ann R Coll Surg Engl       Date:  1994-11       Impact factor: 1.891

3.  Prostate cancer screening (United States).

Authors:  J W Waterbor; A J Bueschen
Journal:  Cancer Causes Control       Date:  1995-05       Impact factor: 2.506

4.  The efficiency of the serum prostate specific antigen levels in diagnosing prostatic enlargements.

Authors:  Ingle Sp; Ingle Ramona
Journal:  J Clin Diagn Res       Date:  2012-11-10

5.  Prostate-specific antigen density--a reliable parameter for the detection of prostate cancer?

Authors:  W F Thon; F Gadban; M C Truss; M Kuczyk; U Hartmann; U Jonas
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

Review 6.  Cancer of the prostate.

Authors:  D P Dearnaley
Journal:  BMJ       Date:  1994-03-19

7.  Prostate disease: management options for the primary healthcare team. Report of a working party of the British Prostate Group.

Authors:  G D Chisholm; S J Carne; J M Fitzpatrick; N J George; J C Gingell; J W Keen; R S Kirby; D Kirk; E P O'Donoghue; W B Peeling
Journal:  Postgrad Med J       Date:  1995-03       Impact factor: 2.401

8.  Screening for Prostate Cancer by Digital Rectal Examination and PSA Determination in Senegal.

Authors:  Lamine Niang; Charles N Kouka; Mohamed Jalloh; Sérigne M Gueye
Journal:  ISRN Oncol       Date:  2011-07-10

9.  Screening for prostate cancer using serum prostate-specific antigen: a randomised, population-based pilot study in Finland.

Authors:  A Auvinen; T Tammela; U H Stenman; I Uusi-Erkkilä; J Leinonen; F H Schröder; M Hakama
Journal:  Br J Cancer       Date:  1996-08       Impact factor: 7.640

Review 10.  Cost analysis of screening for, diagnosing, and staging prostate cancer based on a systematic review of published studies.

Authors:  Donatus U Ekwueme; Leonardo A Stroud; Yanjing Chen
Journal:  Prev Chronic Dis       Date:  2007-09-15       Impact factor: 2.830

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.